ҚАНДЛИ ДИАБЕТИ МАВЖУД COVID-19 АНИҚЛАНГАН БЕМОРЛАРДА ЮҚОРИ НАФАС ЙЎЛЛАРИ ЯЛЛИҒЛАНИШ КАСАЛЛИКЛАРИНИНГ КЛИНИК-ДИАГНОСТИК ТАВСИФИ
##article.subject##:
COVID-19, қандли диабет, юқори нафас йўллари, фарингит, ларингит, яллиғланиш, диагностика##article.abstract##
COVID-19 пандемияси бутун дунёда миллионлаб инсонларнинг ҳаётига таъсир кўрсатди. Унинг юқори нафас йўллари ва ўпкадаги таъсири кенг ўрганилган бўлсада, қандли диабети мавжуд беморларда нафас йўллари яллиғланишининг аниқ клиник ва диагностикавий хусусиятлари тўлиқ аниқланмаган. Шу боис ушбу мақола айнан ана шу масалани ёритишга қаратилган. Ушбу мақола COVID-19 инфекцияси билан касалланган, 2-тур қандли диабетига эга беморларда юқори нафас йўллари яллиғланиш касалликларининг клиник кечиши ва диагностик хусусиятларини таҳлил қилишга бағишланган.
Библиографические ссылки
World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. https://www.worldometers.info/coronavirus/ Accessed: 28 Sept. 2021.
Bikdeli B, Madhavan MV, Jimenez D et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. JACC. 2020. doi:10.1016/j.jacc.2020.04.031.
Cao Y., Liu X., Xiong L. et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J. Med. Virol., 2020; doi: 10.1002/jmv.25 822.
Iba T., Levy J.H., Levi M. и соавт.: Coagulopathy of coronavirus disease 2019. Crit. Care Med., 2020; doi: 10.1097/CCM.0 000 000 000 004 458.
Levi M., Thachil J., Iba T., Levye J.H.: Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7: e438–e440.
Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet.2020;395:507-513.
Han H, Yang L, Liu R et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med.2020;58:1116-1120.
Tao J, Song Z, Yang L. et al. Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department. Br J Dermatol. 2020;182:1477-1478.
Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
Huan H., Lan Y., Liu R., et al. Prominent changes in blood coagulation of patients with SARS-Cov2 infection. Clin Chem Lab Med. 2020; 58(7): 1116–1120. DOI: 10/1515/cclm-2020-0188.
